← Back to headlines
Biotech Executives Sell Millions in Stock After Company Rallies
The CEOs of Kymera and Taysha sold millions of dollars in company stock after significant runs in their respective company's share prices. Kymera's CEO sold $6 million in stock after a 170% run, while Taysha's R&D Chief sold $1.2 million after a 149% run.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
